BioXcel Therapeutics, Inc. (GETTEX:BX20) IPO

BioXcel Therapeutics, Inc.

IPO

Priced at US$11.00 a share on Mar 7, 2018.

Price
US$11.00 a share
Shares offered
5,454,545 shares of common stock
Offering size
US$60 million
Underwriters' option
Up to 818,181 more shares
Listing
BTAI on the Nasdaq Capital Market
Underwriters
Barclays, UBS Investment Bank, BMO Capital Markets, Canaccord Genuity · In the order on the cover
Shares delivered
On or about Mar 12, 2018

Steps

StepWhen
Draft sent to the SEC in confidenceNov 13, 2017
Filed publiclyFeb 12, 2018
Amended 3 timesNewest Mar 5, 2018
Shares registered with an exchangeMar 5, 2018
Declared effective by the SECMar 7, 2018
Final prospectus, with the priceMar 9, 2018

From the cover of the final prospectus (424B4) filed Mar 9, 2018